TKTuğba Koldankaya

Tuğba Koldankaya

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Tuğba Koldankaya has a total of 10 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Doxorubicin-Loaded Poly(Substituted Glycolide)-Based Nanoparticles for Long-Term Storage

    by Tuğba Koldankaya, Mehmet Onur Arıcan, Olcay Mert, Serap Mert

    Preventing agglomeration is crucial for polymeric nanoparticles (PNP) for drug-delivery applications. Suitable conditions for maintaining the size of doxorubicin (DOX)-loaded poly(diisobutyl glycolide) (PDIBG) and poly(diisopropyl glycolide) (PDIPG) nanoparticles (NP) during long-term storage were investigated in this study. After the synthesis of PDIBG and PDIPG homopolymers, DOX-loaded NPs were produced from these homopolymers by using a single-emulsion solvent evaporation method. The optimal formulations of DOX-loaded PDIBG and PDIPG-NPs were obtained with particle sizes of 253 ± 7 nm, PDIs of 0.06 ± 0.02, and an EE value of 58.3%, and particle sizes of 253 ± 7 nm, PDIs of 0.08 ± 0.04, and an EE value of 73.9%, respectively. To extend their shelf life, the developed NPs at three different concentrations (50, 70, and 90 mg/mL) were subjected to a comprehensive lyophilization process at two different freezing temperatures (−20 and −50 °C). As a result of the systematic lyophilization of sugar-containing and sugar-free formulations of DOX-loaded PDIBG and PDIPG-NPs under specific conditions, it was found that they could be stored at 4 and −20 °C for 2 months while maintaining their particle sizes and PDI values in the presence of glucose and sucrose (at 5 and 10% concentrations).


  • Open Access

    Quercetin-loaded mesenchymal stem cell derived extracellular vesicles enhance ovarian function in a cyclophosphamide induced ovarian damage

    by Zeynep Ece Utkan Korun, Zehra Seda Halbutogullari, Yusufhan Yazir, Selenay Furat, Candan Altuntas, Ahmet Ozturk, Tugba Koldankaya, Serap Mert, Erkut Attar

    Background: To investigate whether intraovarian administration of quercetin-loaded extracellular vesicles derived from Wharton’s jelly mesenchymal stem cells (EVs-QUE) improves ovarian function in a cyclophosphamide (CTX)-induced premature ovarian insufficiency (POI) rat model. Methods: Human Wharton’s jelly-derived mesenchymal stem cells (MSCs) were cultured, and extracellular vesicles (EVs) were isolated and characterized by flow cytometry and electron microscopy. Quercetin was loaded onto EVs using ultrasonic incubation to generate EVs-QUE. A rat model of CTX-induced POI was established, and the subjects received intraovarian injections of either EVs or EVs-QUE. Ovarian function was assessed through histological evaluation, immunofluorescence staining, and gene expression analysis. Results: Treatment with EVs-QUE significantly improved ovarian morphology and folliculogenesis, reduced the number of atretic follicles, and decreased Casp3 expression. Proliferation markers ( Ki67 , Pcna ) and antioxidant genes ( Nrf2 , Sod1 ) were upregulated. Additionally, steroidogenesis- and oocyte-related genes ( Star , Gdf9 , Bmp15 ) showed increased expression. Although systemic hormonal alterations were limited, local tissue analysis confirmed a regenerative effect in the EVs-QUE group. Conclusions: Quercetin-loaded EVs derived from Wharton’s jelly MSCs enhanced ovarian recovery in a CTX-induced POI model through anti-apoptotic, pro-proliferative, and antioxidant pathways. These findings suggest that intraovarian administration of EVs-QUE may represent a promising strategy for fertility preservation and warrant further investigation in long-term and translational studies.


  • Extending the Shelf Life of Doxorubicin Loaded PLGA Nanoparticles with Cryoprotectants

    by Tuğba Koldankaya, Serap Mert

    Sugars, as cryoprotectants, can be added to NP formulations before lyophilization to ensure that NPs retain their size during long‐term storage. In this study, mannitol, glucose, and sucrose were used at different concentrations to extend the storage time of doxorubicin (DOX)‐loaded PLGA‐NPs prepared using two different copolymer ratios (75 : 25 and 50 : 50) at different storage temperatures (−20, +4, and +25 °C). After lyophilization, a glucose or sucrose concentration of only 5 % for DOX‐PLGA‐75 : 25‐NP and a glucose concentration of 10 % for DOX‐PLGA‐50 : 50‐NP were found to prevent agglomeration for up to 4 months at −20 °C. It is noteworthy that after storage at 4 °C for up to 4 months, agglomeration was prevented using 5 % sucrose and 10 % glucose in DOX‐PLGA‐50 : 50‐NP and 10 % sucrose content in both NP types. On the other hand, as expected, no sugar type or concentration could prevent agglomeration during long‐term storage of NPs at 25 °C. The sizes and encapsulation efficiencies (EE%) before lyophilization were 221.8±2.20 and 45.4 % for DOX‐PLGA‐50 : 50‐NP and 221.5±1.31 and 48.7 % for DOX‐PLGA‐75 : 25‐NP, respectively. Furthermore, the release profiles and encapsulation of DOX in both NPs were investigated by UV‐Vis analyses. DSC analysis revealed that DOX was present in the free form and amorphous in the NPs. Consequently, PLGA copolymer ratios were found to have an impact on the long‐term stability of DOX loaded PLGA lyophilizates, and DOX‐loaded NPs prepared with PLGA 75 : 25 or PLGA 50 : 50 can be stored at −20 and +4 °C for up to 4 months when combined with appropriate sugar contents and concentrations, demonstrating the versatility of these materials.